Nutu™ Digital Health Platform for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive primary care-based behavioral obesity treatment program using a Zelen randomized controlled trial design.
Who Is on the Research Team?
Drew Sayer, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the standard 12-month FLOW program, with or without the Nutu™ digital health platform
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Nutu™
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants receive standard FLOW care and are offered access to the Nutu™ digital health platform, which may be accepted or declined.
Participants receive the standard 12-month FLOW program including nutrition counseling, physician visits, and behavioral health support.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Willow Laboratories, Inc.
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.